Natural and semi-synthetic antibiotics

<p>Decladinose roxithromycin is a novel drug that can be used for the diagnosis and treatment of disorders related to the mutation. Decladinose roxithromycin has been shown to be effective in the detection and treatment of mutants, such as those related to cystic fibrosis.</p>

<p>Please enquire for more information about L-Piperacillin including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Cefixime EP Impurity C disodium is an impurity in the drug Cefixime EP. It is a by-product of the synthesis process, which can be removed by a purification process. This product is an analytical standard and is used for qualitative analysis in HPLC. It is also used as a research and development standard for drug development. This product has been classified as a niche impurity since it only occurs at trace levels in the drug product, but it may have pharmacological relevance to some patients. This impurity can be synthesized from natural or synthetic sources and is available for custom synthesis to meet specific customer needs.</p>

<p>Ciprofloxacin impurity D hydrochloride is a drug product that is an analytical standard. It is also a natural impurity found in Ciprofloxacin. This compound has been synthesized and manufactured to be used as an impurity standard. It exhibits the same physical, chemical, and biological properties as Ciprofloxacin. The CAS number for this substance is 526204-10-4. Impurities such as Ciprofloxacin impurity D hydrochloride may be present in the finished drug product if they are not removed during the manufacturing process. Chemical reactions may also lead to the formation of these substances. The presence of these substances can affect the quality of the drug product and may lead to adverse effects for patients who use them.<br>CAS No.: 526204-10-4<br>Molecular Weight: 258.25<br>Formula: (C8H6ClF2NOS)</p>

<p>Pseudomonic acid D sodium is a drug product that is used for the development of novel drugs. It is a natural metabolite of pseudomonic acid A, which is found in the fungus Pseudomonas sp. Pseudomonic acid D sodium is used as an analytical standard to aid in the identification of pseudomonic acid A and its metabolites. Pseudomonic acid D sodium can be synthesized by reacting 2-chloro-4-nitrobenzene with sodium bisulfate. The synthesis proceeds through a sequence of three reactions, namely nucleophilic substitution, electrophilic substitution, and hydrolysis. The structure of pseudomonic acid D sodium has been confirmed using nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS).</p>

<p>Roxithromycin impurity I is a natural metabolite of roxithromycin. The substance has been synthesized in order to serve as an analytical impurity standard for HPLC. Roxithromycin impurity 1 is also a metabolite of roxithromycin, which has been shown to produce pharmacological effects similar to those seen with the parent compound. Roxithromycin impurity I is not an API, but has been developed as a HPLC analytical impurity standard and will be used for metabolism studies.</p>

<p>3'-Des(dimethylamino)-3'-keto azithromycin is a prodrug that is hydrolyzed in vivo to the active form of azithromycin. 3'-Des(dimethylamino)-3'-keto azithromycin has an elution time of about 10 minutes on a C18 column, which is considerably longer than the 5-minute elution time for azithromycin. The chromatogram of 3'-Des(dimethylamino)-3'-keto azithromycin shows two peaks, one at 6 minutes and another at 10 minutes. These two peaks are due to impurities in the drug product, namely itraconazole and fluconazole. 3'-Des(dimethylamino)-3'-keto azithromycin has shown bioequivalence with its parent molecule, azithromycin.</p>

<p>Ceftazidime t-butyl ester is a prodrug of ceftazidime. It is a crystalline, stable form of the drug that can be dissolved in an organic solvent. Ceftazidime t-butyl ester has an average UV detection wavelength with a linear range of 200-600 nm and can be detected at a wavelength of 220 nm. This drug is used to treat infections caused by bacteria, including those that are resistant to other antibiotics, such as penicillin or ampicillin. Ceftazidime t-butyl ester has been shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium perfringens, although is not active against acid-fast bacteria such as Mycobacterium tuberculosis or Mycobacterium avium complex.</p>

<p>4-Epiminocycline is a pharmaceutical preparation that belongs to the class of antibiotics. It is a drug substance that is used in the manufacture of other drugs and as an individual drug for the treatment of various skin conditions and for the prevention of malaria. 4-Epiminocycline has been shown to be effective against bacteria by binding to DNA, preventing transcription and replication. The drug binds to plasma proteins and erythrocytes with high affinity, but it does not bind well to intestinal cells or lung tissue. 4-Epiminocycline has been shown to be effective against Mycobacterium tuberculosis, Mycobacterium avium complex, Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis. This antibiotic also prevents the formation of biofilms by these bacteria.</p>

<p>Erythromycin impurity K is a synthetic impurity of erythromycin, which is an antibiotic drug product. It is typically found in pharmaceutical products that are made from natural sources and is used as a research and development (R&amp;D) standard for the pharmacopoeia. Erythromycin impurity K can be purified by HPLC or other means to create high purity standards for analytical purposes. The chemical name of this compound is 3-[[[3-(2-Amino-4-thiazolyl)-1,2,4-triazol-5-yl]amino]methyl]-1H-indole.</p>

<p>Metabolite of mupirocin</p>

<p>N-[(2E)-6,6-Dimethyl-2-hepten-4-ynyl]-1-naphthalenemethanamine (DHEA) is a human metabolite and an endogenous hormone. DHEA has been shown to have antifungal activity against Candida albicans in vitro. It also possesses an inhibitory effect on the growth of some fungi that are resistant to azole drugs, such as Coccidioides immitis, Cryptococcus neoformans and Blastomyces dermatitidis. DHEA has been used in the treatment of pediatric patients with chronic granulomatous disease and is currently being evaluated for use in other pediatric conditions.</p>

<p>Cefixime Impurity A is a drug product that is used for analytical purposes. It is an impurity of cefixime.</p>

<p>Please enquire for more information about 2′,4′′-Bis-O-(trimethylsilyl)-erythromycin 9-[O-(1-ethoxy-1-methylethyl)oxime] including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Lincomycin B is a chemical compound that belongs to the group of antimicrobial agents. It is used in the treatment of viral infections and has been shown to have an effect against HIV-1, herpes simplex virus, and influenza A virus. Lincomycin B inhibits protein synthesis by binding to the ribosomes in bacteria and inhibiting peptide elongation. The optimum concentration for this compound is 0.2 mM with a minimum inhibitory concentration of 1 mM. Lincomycin B can be synthesized by reacting sodium hydroxide solution with hydrochloric acid or hydroxide solution at a temperature range from 30 °C to 70 °C.</p>

<p>The impurity is a natural product and an API impurity. The impurity is synthesized by the rearrangement of (E/Z)-FK-506 26,28-allylic ester. This impurity has been shown to be present in drug products at concentrations up to 0.0025% w/w. It is found in analytical samples at concentrations up to 0.02% w/w, which may be due to its use as a HPLC standard. The impurity has been studied for metabolism in rats and rabbits and is not metabolized by microsomal enzymes or conjugated with glucuronic acid. The compound has also been shown to have anti-inflammatory properties in mice models and has no cardiotoxic effects on Balb/c mice.</p>

<p>4-[2-[[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]thio]-4-thiazolyl]-1-methylpyridinium Chloride Monohydrochloride is a drug product under development for the treatment of bacterial infections. 4-[2-[(6R,7R)-7Amino--2carboxy8oxo5thia1azabicyclo[4.2.0]oct2en3yl]thio]-4thiazolyl]-1methylpyridinium Chloride Monohydrochloride is an impurity in the API Methicillin (CAS No. 40082764). Impurities are not necessarily undesirable and may have substantial therapeutic value or provide a desired</p>

<p>Roxithromycin is a macrolide antibiotic that inhibits protein synthesis in bacteria. It binds to the 50S ribosomal subunit, thereby inhibiting bacterial growth. Roxithromycin has been used to diagnose intestinal and esophageal diseases, inflammatory diseases, and cancer. There are some cardiac effects associated with Roxithromycin that may be related to its ability to inhibit serotonin reuptake. This drug also has anti-inflammatory properties and has been shown to be effective against influenza virus infections as well as other infectious diseases such as tuberculosis and HIV/AIDS.</p>

<p>Enrofloxacin impurity E is a product of the synthesis of enrofloxacin, with high purity and analytical standards. It is synthesized from natural products, and it can be used as an impurity standard for HPLC analysis. Enrofloxacin impurity E also has pharmacopoeia and CAS number 1369495-59-9. This substance is used in drug development and research to study metabolism.</p>

<p>(trans)-4-Propyl-1-methyl-L-proline is a synthetic compound that has been used in the past as an impurity standard in the synthesis of several drugs, including metaxalone and aminopyrine. It is also found to have pharmacological effects on its own and was used as a drug product for the treatment of rheumatoid arthritis. (trans)-4-Propyl-1-methyl-L-proline is not listed in any pharmacopoeia or international list of approved drugs.</p>